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1. Introduction
Inflammation is the most common biological re-
action to a variety of stimuli and local injury [1]. 
Inflammatory reactions can be triggered by phys-
ical or chemical trauma, invading organisms and 
antigen-antibody reactions, and is often exacer-
bated by the resultant swelling or edema of tissue, 
pain (due to increased pressure in tissues during 
edema formation or by inflammatory mediators) 
or even cell damage [2]. Thus the employment 
of anti-inflammatory agents may be helpful in the 
therapeutic treatment of those pathologies associ-
ated with inflammatory reaction. However, the side 
effects of the currently available anti-inflammatory 
drugs pose a major problem in their clinical use. 
For instance, some non-steroidal anti-inflammatory 
drugs (NSAIDs) may cause gastric ulceration and renal 
damage [3,4]. Owing to safety concerns associated 
with the use of synthetic anti-inflammatory and an-
algesic agent, the public prefer to take natural anti-
inflammatory and analgesic treatments from edible 
materials such as fruits, spices, herbs and vegetables. 
Therefore, the development and utilization of more 
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effective anti-inflammatory and analgesic agents 
of natural origin are desired.
Members of the Elephantopus genus are widely 
used in Southeast Asian folk medicine. Ele-
phantopus spp is believed to have anti-pyretic, 
anti-inflammatory and emollient activities [5]. In 
Malaysia, E. tomentosus (Et) is taken internally as 
a diuretic, febrifuge, analgesic, anti-helminthic and 
anti-inflammatory agent. Et is also applied exter-
nally as a poultice for abdominal pains. However, 
very few scientific studies on Et have been con-
ducted. Recently, Et was found to exhibit antio-
xidant properties and a liver protective effect on 
carbon tetrachloride-induced liver toxicity [6]. With 
this background, the present study aimed to investi-
gate the analgesic and anti-inflammatory effects of 
E.tomentosus ethanol extract (EtE) using different 
pharmacological experimental models in an attempt 
to validate its ethnomedical use.
2. Materials and Methods
2.1. Materials
Carrageenan type IV (Carrageenan), sodium hydrox-
ide (NaOH), ferric chloride (FeCl3), potassium chlo-
ride, sodium chloride (NaCl), potassium hydroxide 
(KOH), Chicago sky blue, and indomethacin were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Carboxymethylcellulose (CMC) was supplied from 
British Drug House (Poole, England). Ethanol was 
purchased from Riedel-de Haën (Seelze, Germany). 
Mayer reagent was obtained from Fluka Chemie GmbH 
(Buchs, Switzerland). Glacial acetic acid, hydro-
chloric acid (HCl) and sulfuric acid (H2SO4) were 
obtained from Merck (Darmstadt, Germany). Mor-
phine sulfate was purchased from Remedi Pharma-
ceutical (Selangor, Malaysia). 
2.2. Preparation of plant extract
The plant was obtained from Permatang Damar 
Laut, Penang, Malaysia. The plant was sent to the 
Herbarium, School of Biological Sciences, Universiti 
Sains Malaysia for identification. The herbarium 
voucher number is 10832. After identification, the 
plant was dried in an oven (Memmert, Germany) at 
45ºC and ground into powder. The powered plant 
material (250 g) was put into a thimble and extracted 
with 5 L of 95% ethanol in a soxhlet extractor for 
3 days. The extract was concentrated using Büchi 
RE121 rotary evaporator (Büchi Labortechnik AG, 
Switzerland) and subsequently dried in a Hetovac 
VR-1 freeze dryer (Heto Lab. Equipment AS, 
Denmark). The yield (EtE) obtained was found to 
be 14% (w/w) of the dried plant.
2.3. Animals
Male and female Sprague Dawley (SD) rats (age, 
8−12 weeks; weight, 150−200 g) and Institute 
Charles River strain (ICR) mice (age, 3−4 weeks; 
weight, 25−32 g) were used for the experiments. 
The animals were kept under stan dard condi-
tions (26−30ºC) with free access to food (normal 
laboratory chow, Gold Coin Feed Mills Sdn Bhd, 
Malaysia) and tap water. The animals were fasted 
for 6 hours prior to the experiments and acclima-
tized to laboratory conditions for 7 days before 
commencement of experiments. All the experi-
mental procedures on animals were carried out 
in accordance with the regulations and guidelines 
of the Animal Ethics Committee, Universiti Sains 
Malaysia.
2.4. Acute toxicity
Organisation for Economic Co-operation and De-
velopment guidelines for testing of chemicals were 
adhered. Healthy female SD rats were subjected 
to tests according to the acute oral toxicity up-
and-down procedure (limit test). All experimen tal 
animals were maintained under close observation 
for 14 days.
2.5.  Carrageenan-induced rat hind 
paw edema
The anti-inflammatory activity was evaluated ac-
cording to the method described by Winter et al 
(1962) [7]. A total of 30 male rats were used in the 
experiment. They were divided into five groups of 
six rats each. Carrageenan was freshly prepared as 
1% (w/v) suspension in sterile 0.9% NaCl before the 
experiment. A volume of 0.1 mL of carrageenan was 
injected into the plantar tissue of the rat right hind 
paw. EtE (250, 500, and 1000 mg/kg) and indometh-
acin (10 mg/kg) were administered by oral gavage 
1 hour before carrageenan injection. The animals in 
the control group received 1% of CMC in distilled 
water. The footpad thickness was mea sured simply 
by placing the unanesthetized animal foot between 
the anvil and spindle of peacock dial thickness 
gauge of a micrometer (Ozaki Ltd., Japan) before 
injection and 1, 3 and 5 hours after the injection of 
carrageenan. The percentage in thickness changes 
of the hind paw was calculated according to the 
following formula:
% increase in thickness = (Ct − C0)/C0 ˜  100
Ct is the thickness of hind paw at t hour. C0 is the 
thickness of hind paw before carrageenan was 
injected.
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2.6.  Acetic acid-induced peritoneal 
capillary dye leakage test
The capillary permeability or dye leakage test was 
performed by modifying a previously reported 
method (Whittle, 1964) [8]. The ICR mice (four 
males and four females in each group) were given 
EtE (250, 500 and 1000 mg/kg) and indomethacin 
(10 mg/kg). The control group was orally given 1% 
CMC in distilled water. After 25 minutes, each ani-
mal was given an intravenous injection of 0.1 mL of 
4% solution of Chicago sky blue in normal saline. 
After 30 minutes, 0.2 mL of 0.25% (v/v) glacial ace-
tic acid solution in normal saline was injected in-
traperitoneally. After an additional 20 minutes, 
the mice were killed by cervical dislocation, and 
the visceral organs were subsequently exposed. A 
period of 1 minute was allowed for blood to drain 
away from the abdominal wall and jugular vein. 
The animals were then held by a flap of the ab-
dominal wall and the exposed visceral organs were 
continuously irrigated with distilled water in a 
petri dish. The combined washings were filtered 
through glass wool and filled a 10 mL volumetric 
flask. Then, 0.1 mL of 0.1 N NaOH was subsequently 
added to deproteinize the filtrate. The absorbance 
was measured using a Hitachi U-2000 spectropho-
tometer at 590 nm (Hitachi, Japan). The total con-
centration of Chicago sky blue was determined as 
μg/10 mL from a standard calibration curve.
2.7. Analgesic studies
2.7.1. Hot plate test 
The mice were placed on an Ugo Basile 7280 hot 
plate (Ugo Basile, Italy), which was maintained at 
55 ± 0.5ºC. The time between placement and licking 
of the paws or jumping was recorded as latency sec-
ond. The latency was recorded at 15, 30, 45, 60 
and 90 minutes after administration of EtE (250, 500, 
and 1000 mg/kg, p.o.), morphine sulfate (8 mg/kg, 
s.c.) and vehicle (10 mL/kg of 1% CMC, p.o.) [2]. 
Mor phine sulfate was used as a reference standard.
2.7.2. Tail flick test 
The nociception was assessed using an Ugo Basile 
7360 tail flick apparatus (Ugo Basile, Italy). Briefly, 
the tail flick test response was done by measuring 
the time taken to withdraw the tail from the heat 
source [2]. Each mouse was encased in a small alu-
minum chamber with the middle portion of the tail 
placed over the light beam of the tail flick appara-
tus. A maximum cut-off time of 10 seconds was ob-
served to minimize undue tissue damage as a result 
of over exposure of the tail to heat. The reading was 
taken 1 hour after administration of EtE (250, 500, 
and 1000 mg/kg, p.o.), morphine sulfate (8 mg/kg, 
s.c.) and vehicle (10 mL/kg of 1% CMC, p.o.). For 
the purpose of calculation, an animal not respond-
ing by the cut-off time of 10 seconds was arbitrar-
ily assigned a response time of 10 seconds.
2.7.3.  Carrageenan-induced rat hind paw 
hyperalgesia pain threshold test 
method
The hyperalgesia pain threshold of the inflamed rat’s 
right hind paw was investigated by subjecting the 
hind paw to a constant force following the method 
of Winter and Flataker [9]. The various treatments 
[EtE (250, 500, and 1000 mg/kg, p.o.), indomethacin 
(10 mg/kg, p.o.) and 1% CMC (10 mL/kg, p.o.)] were 
respectively given 2 hours after a sub-plantar injec-
tion of 0.1 mL of 1% carrageenan. Pain threshold was 
measured mechanically using a Letica Analgesy-meter 
LI7306 (Letica Scientific Instruments, Spain) before 
the injection of carrageenan and then at 4 and 6 hours 
post-injection. The pain threshold (g) was measured 
when the rat withdrew its hind paw, struggled or vo-
calized [10]. The percentage change of pain threshold 
was calculated according to the following formula:
% change of pain = (Pt − P0)/P0 ˜  100
Pt is the pain threshold at t hour and P0 is the pain 
threshold before carrageenan was injected.
2.7.4. Acetic acid-induced writhing test
The method of Koster et al [11] was used in this 
study. EtE (250, 500 and 1000 mg/kg), paracetamol 
(100 mg/kg) and 1% CMC were orally administered 
to respective groups of mice. One hour later, each 
mouse was injected with 0.6% (v/v) acetic acid 
(10 mL/kg, i.p.). The number of writhings during 
the 15 minutes was recorded.
2.8. Phytochemical analysis
Preliminary phytochemical analysis of the extract 
was performed using the following method:
Alkaloids: 1 mL of 1% HCl (v/v) was added to 3 mL of 
plant extract in a test tube. The mixture was heated 
for 20 minutes, cooled and filtered. Two drops of 
Mayer’s reagent was added to 1 mL of the filtrate. 
A creamy precipitate indicates the presence of 
alkaloids in the extract [12].
Phenolics: Two drops of 5% FeCl3 (w/v) was added 
to 1 mL of the plant extract. A greenish precipitate 
indicates the presence of phenolics [13]. 
Cardiac glycosides: (Salkowski Test) − 1 mL of 
the extract was added to 2 mL of chloroform. 
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Subsequently, H2SO4 was carefully added on the in-
ner side of the test tube. A reddish-brown color at 
the interface indicates the presence of a glycone 
portion of cardiac glycoside [14].
Tannins: 1 mL of freshly prepared 10% (w/v) 
ethanolic KOH was added to 1 mL of the extract. A 
dirty white precipitate indicates the presence of 
tannins [15].
Flavonoids: 1 mL of 10% (w/v) NaOH was added 
to 3 mL of the extract. A yellow coloration indi-
cates the presence of flavonoids [13].
Saponins: (Frothing test) − In a test tube, 2 mL 
of extract was shaken vigorously with water for 
2 minutes and warmed. Froth formation that per-
sists upon warming indicates the presence of 
saponins [16].
Steroids: Five drops of concentrated H2SO4 
were added to 1 mL of the extract. Red coloration 
indicates the presence of steroid [17].
2.9. Statistical analysis
The results are reported as mean ± standard error 
mean (S.E.M.). One-way Analysis of Variance (ANOVA) 
followed by two-tailed Dunnett’s multiple compar-
ison test was used for comparisons. The statistical 
methods were performed using SPSS version 10.0 
(SPSS Inc., Chicago, IL, USA). A p value of < 0.05 was 
set as statistical significant.
3. Results
3.1. Acute toxicity study
In the acute toxicity study, EtE at a dose of 
5000 mg/kg caused neither visible signs of toxicity 
nor mortality. A female rat given single dose EtE 
(5000 mg/kg) survived after the observation peri-
ods, and then two additional female rats were given 
EtE (5000 mg/kg) and observed for 14 days. All three 
rats survived during the observation period.
3.2.  Carrageenan-induced rat hind 
paw edema test
In the carrageenan-induced edema test, the per-
centage changes of right hind paw thickness by EtE 
and indomethacin are shown in Figure 1. For the 
control group, carrageenan caused localized edema 
starting 1 hour after injection (increased to 30.08 ± 
7.39%). The swelling increased progressively to 
72.62 ± 7.3% at 5 hours after carrageenan injection. 
Indomethacin (10 mg/kg, p.o.) caused a significant 
attenuation in hind paw edema 3 and 5 hours after 
injection of carrageenan (n = 6; p < 0.001). As with 
indomethacin, rats treated with the EtE at a dose 
of 1000 mg/kg showed a significant inhibition (n = 6; 
p < 0.05) in magnitude of swelling 3 and 5 hours fol-
lowing carrageenan administration. However, no 
sig nificant changes in carrageenan-induced paw 
edema were observed at EtE doses of 250 and 
500 mg/kg throughout the whole experimental pe-
riod or at 1 hour following the injection of carra-
geenan in rats treated with 1000 mg/kg.
3.3.  Acetic acid-induced peritoneal 
capillary dye leakage test 
The results of acetic acid-induced peritoneal cap-
illary dye leakage are shown in Figure 2. The total 
amount of dye was determined from a standard 
curve. EtE significantly reduced the Chicago sky 
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Figure 1   Effect of the E.tomentosus extract (EtE) and 
indomethacin on the carrageenan-induced hind paw 
edema. *p < 0.01 and †p < 0.001 from one-way analysis of 
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Figure 2   Effects of E.tomentosus extract (EtE) and 
indomethacin on peritoneal capillary permeability test. 
*p < 0.01 and †p < 0.001 from one-way ANOVA against con-
trol group.
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blue from leaking at the dose of 1000 mg/kg (n = 8; 
p < 0.01) as compared with the control. Indo-
methacin (10 mg/kg) also significantly reduced the 
dye leakage as compared with the control (n = 8; 
p < 0.001).
3.4. Hot plate and tail flick tests
As shown in Table 1 and Table 2, it can be clearly 
observed that morphine produced a significant in-
crease (p < 0.001) in the response time in the hot 
plate and tail flick experiment, respectively. EtE, 
in contrast, did not significantly alter the response 
time at all the tested doses.
3.5.  Carrageenan-induced rat hind paw 
hyperalgesia pain threshold test 
Indomethacin at a dose of 10 mg/kg p.o. caused a 
significant increase in the pain threshold 4 and 6 
hours after carrageenan injection (Figure 3, n = 6; 
p < 0.05 and p < 0.01, respectively). Likewise, EtE 
at a dose of 1000 mg/kg showed a significant in-
crease in pain threshold level at 4 and 6 hours fol-
lowing carrageenan administration (Figure 3, n = 6; 
p < 0.05). However, EtE at doses of 250 and 500 mg/kg 
did not produce any significant changes in the pain 
threshold during in the experiment.
3.6. Acetic acid-induced writhing in mice
Figure 4 demonstrates that EtE (1000 mg/kg) and pa-
racetamol (100 mg/kg) caused an inhibition of the 
writhing response induced by acetic acid (n = 6; 
p < 0.05 and p < 0.01, respectively). The analgesic ef-
fect of EtE on the writhing test was dose-dependent. 
The percentage inhibition of writhing produced 
by EtE at the doses of 1000, 500 and 250 mg/kg in 
mice were 23.1, 8.4 and 2.5%, respectively. Para-
cetamol (100 mg/kg) exhibited approximately 28.6% 
inhibition.
3.7. Phytochemical analysis
Preliminary phytochemical analysis of the extract 
revealed the presence of flavonoids, saponins, 
tannins, cardiac glycosides, steroids and phenolic 
compounds (data not shown).
Table 1 Effect of various treatments on the hot plate test*
 Response time (s) (n = 8)
Group
 15 30 45 60 90
Control 10.81 ± 1.06 10.94 ± 1.45 11.41 ± 1.37 10.63 ± 0.9 11.06 ± 0.89
Morphine (8 mg/kg) 14.30 ± 1.92† 18.14 ± 1.99† 21.95 ± 1.81† 30.10 ± 2.8† 21.95 ± 2.05†
EtE (mg/kg)
   1000 10.24 ± 0.76 12.08 ± 0.82 11.10 ± 1.60 10.54 ± 1.17 12.23 ± 1.33
    500 9.84 ± 0.80 11.46 ± 1.06 9.99 ± 0.97 11.94 ± 0.81 12.11 ± 1.54
    250 8.90 ± 0.91 12.00 ± 1.24 10.39 ± 0.87 12.96 ± 0.96 10.86 ± 1.20
*Data presented as mean ± standard error mean; †p < 0.001, evaluated by one-way analysis of variance (ANOVA) against control 
group.
Table 2   Effect of Elephantopus tomentosus extract 
(EtE) and morphine treatments on tail flick*
Group Response time (s) (n = 8)
Control 1.88 ± 0.10
Morphine (8 mg/kg) 8.9 ± 0.56†
EtE
   1000 1.94 ± 0.14
   500 1.88 ± 0.17
    250 2.01 ± 0.26
*Data presented as mean ± standard error mean; †p < 0.001, 
evaluated by one-way ANOVA against control group.
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indomethacin on the pain threshold of the carrageenan-
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4. Discussion
In the present study, the anti-inflammatory and 
analgesic properties of EtE were investigated. The 
carrageenan-induced edema test was selected be-
cause of its sensitivity in detecting orally active 
anti-inflammatory agents, particularly natural prod-
ucts, and as an acceptable and reliable method for 
acute anti-inflammatory studies [18]. This study 
demonstrates that EtE is effective in reducing car-
rageenan-induced hind paw edema. EtE shows a 
dose-dependent reduction in the hind paw edema 
at 5 hours after carrageenan administration. Gen-
erally, two different phases of inflammation are in-
volved in carrageenan-induced edema [19,20]. The 
first phase (0 − 2.5 hours after injection of carra-
geenan) mainly results from concomitant release of 
inflammation mediators, namely histamine, seroto-
nin and kinins from damaged surrounding tissues. 
The second phase (3 − 6 hours after injection of car-
rageenan) is mediated by bradykinin, leukotrienes, 
and prostaglandins produced by the macrophages 
and sustained by released prostaglandins [18]. Oral 
administration of EtE (1000 mg/kg) suppressed the 
edematous response 3 hours after carrageenan in-
jection and this effect continued for up to 5 hours. 
These results indicate that EtE acts in the second 
phase, which mainly involves arachidonic acid 
metabolites [20−22].
Vascular permeability was induced by acetic 
acid. Acetic acid causes an increase in prostaglan-
dins, serotonin and histamine release. This in turn 
leads to a dilation of the capillary vessels and thus 
an increase in vascular permeability. As a conse-
quence, fluid and plasma proteins are extravasated 
and lead to edema formation [23]. EtE markedly in-
hibited the acetic acid-induced increase in vascular 
permeability in mice. This result suggests that EtE 
may produce an anti-inflammatory action through 
inhibiting the inflammatory mediators of the acute 
phase of inflammation. In the above acute in-
flammatory models, EtE showed anti-inflammatory 
activity similar to the positive control drug indo-
methacin, a NSAID which is known to nonselec-
tively inhibit the action of the cyclooxygenase 
enzymes. These data suggest that EtE has an anti-
inflammatory property, probably like indomethacin, 
acting through the inhibition of the inflammatory 
mediators of the acute phase of inflammation. 
However, further work needs to be carried out to 
evaluate the effect of EtE on the enzymatic activ-
ity of cyclooxygenase.
The analgesic properties of EtE were studied 
using four important laboratory models, namely 
the hot plate latency method, tail flick latency 
method, acetic acid-induced writhing method and 
carrageenan-induced hyperalgesia method. The 
hot plate and tail flick methods are sensitive to 
centrally-acting analgesic drugs [24,25] while car-
rageenan-induced hyperalgesia and acetic acid 
models typically resemble human clinical pain con-
ditions and are sensitive to peripherally-acting an-
algesic drugs [26,27]. The hot plate and tail flick 
tests were undertaken to verify if EtE could show 
any central anti-nociceptive effect. In the hot 
plate and tail flick tests, EtE hardly produced any 
significant effect. It did not increase tail flick re-
sponse and latency of the licking or jumping of 
mice as compared with those obtained for the con-
trol group. It is known that NSAIDs do not usually 
increase the pain threshold level in normal tissues, 
unlike central anesthetics and narcotics, hence, it 
can be suggested that EtE has no central analgesic 
effect.
Previous studies have showed that sub-dermal 
injections of carrageenan into the rat paw caused a 
marked hyperalgesia 4 hours post-injection, which 
was mainly due to prostaglandins [28]. The 1000 mg/
kg EtE-treated rats showed a significant increase 
in pain threshold level at 4 and 6 hours after carra-
geenan injection. The intraperitoneal administra-
tion of acetic acid induced a stereotypical behavior 
in mice, which is characterized by abdominal con-
tractions, movements of the body as a whole, twist-
ing of dorsoabdominal muscles and a reduction in 
motor activity and coordination [29]. The algesic 
mechanism of abdominal writhing involves the re-
lease of arachidonic acid via prostaglandin biosyn-
thesis and sympathetic nervous system mediators 
[30−32]. Thus, the results obtained for the writhing 
test using acetic acid are similar to those obtained 
for the edematogenic test using carrageenan, since 
EtE at a dose of 1000 mg/kg significantly inhibited 
the writhing activity. Therefore, anti-inflammatory 
Figure 4   Effect of the E.tomentosus extract (EtE) and 
paracetamol on the acetic acid-induced writhing test. 
*p < 0.05 and †p < 0.01 from one-way ANOVA against con-
trol group.
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substances in EtE may also be involved in peripheral 
analgesic activity [33].
Phytochemical analysis also showed that the 
extract contains saponins, cardiac glycosides, phe-
nolic compounds, tannin, steroid, and flavonoids. 
Flavonoids, saponins, tannins, phenolic compounds, 
and glycosides have all been associated with vari-
ous degrees of anti-inflammatory and analgesic ac-
tivities [33−37]. Therefore, the anti-inflammatory 
and analgesic effects observed in this study are 
perhaps due to the activity(s) of one or a combina-
tion of some of the identified classes of compounds. 
The methods used for the identification of phy-
tochemical constituents are preliminary in nature. 
Therefore, further studies are required to identify 
the presence of these constituents and their rela-
tive concentration in the leaves of the plant.
Based on the classification of Loomis and Hayes 
[38], substances with an LD50 between 500 and 
5000 mg/kg body weight are regarded as being slightly 
toxic, while those between 5000 and 15,000 mg/kg 
body weight are regarded as practically non-toxic. 
Results presented herein show that EtE has an LD50 
value of more than 5000 mg/kg p.o., suggesting that 
EtE is practically non-toxic.
In conclusion, the present study indicates that 
EtE has both anti-inflammatory and analgesic 
effects, similar to those observed with indometh-
acin. The mechanism of action of EtE might be 
associated with the inhibition of prostaglandin syn-
thesis as observed for most NSAIDs. Further inves-
tigation on how EtE interferes with the mechanism 
of prostaglandin synthesis is needed. Our study 
shows that EtE has the potential to be developed 
as a new product for pain and inflammation 
management.
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